CPMG Inc - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 3 filers reported holding REATA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
CPMG Inc ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$295,368,026
+12.1%
2,896,9010.0%59.26%
+11.5%
Q1 2023$263,386,239
+139.3%
2,896,9010.0%53.13%
+92.2%
Q4 2022$110,053,269
+51.2%
2,896,9010.0%27.64%
+93.5%
Q3 2022$72,799,000
-17.3%
2,896,9010.0%14.28%
-19.3%
Q2 2022$88,037,000
-7.2%
2,896,9010.0%17.69%
+11.1%
Q1 2022$94,902,000
+24.2%
2,896,9010.0%15.92%
+13.0%
Q4 2021$76,391,000
-73.8%
2,896,9010.0%14.09%
-56.2%
Q3 2021$291,457,000
-28.9%
2,896,9010.0%32.14%
-52.6%
Q2 2021$409,998,000
+42.0%
2,896,9010.0%67.78%
+22.7%
Q1 2021$288,821,000
-19.3%
2,896,9010.0%55.24%
+0.1%
Q4 2020$358,115,000
+20.0%
2,896,901
-5.4%
55.16%
+11.1%
Q3 2020$298,453,000
-37.6%
3,063,5670.0%49.63%
-22.2%
Q2 2020$477,978,000
+8.1%
3,063,5670.0%63.81%
-16.9%
Q1 2020$442,195,000
-29.4%
3,063,5670.0%76.81%
+62.9%
Q4 2019$626,285,000
+158.0%
3,063,567
+1.3%
47.15%
+73.7%
Q3 2019$242,745,000
-14.9%
3,023,3490.0%27.14%
-19.5%
Q2 2019$285,253,000
+10.4%
3,023,3490.0%33.71%
+9.3%
Q1 2019$258,406,000
+52.4%
3,023,3490.0%30.83%
+105.6%
Q4 2018$169,610,000
-28.8%
3,023,349
+3.8%
15.00%
-9.5%
Q3 2018$238,128,000
+133.8%
2,912,5230.0%16.57%
+71.8%
Q2 2018$101,851,000
+70.5%
2,912,5230.0%9.64%
+44.5%
Q1 2018$59,736,000
-27.6%
2,912,5230.0%6.68%
-19.9%
Q4 2017$82,483,0002,912,5238.34%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
DekaBank Deutsche Girozentrale 17,000$2,9300.01%
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO 93,711$1,6120.00%
IFP Advisors, Inc 300$51,7080.00%
View complete list of REATA PHARMACEUTICALS INC shareholders